Physician profile
Teri Lynn Stapleton
NPI 1790053726
$9,260.79
in general payments reported to CMS, 2019-2025
64 companies · $1,250 in 2025
The $1,250 reported for 2025 was more than what 90% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $606 · 2020: $908 · 2021: $1,363 · 2022: $1,639 · 2023: $1,515 · 2024: $1,980 · 2025: $1,250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,744.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,744.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,014.38 | 2019-2025 | Ubrelvy, Qulipta |
| Astrazeneca Pharmaceuticals LP | $922.98 | 2019-2024 | Farxiga, Breztri, Airsupra |
| Novo Nordisk INC | $816.15 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $714.33 | 2019-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Pfizer INC. | $650.67 | 2019-2025 | |
| Lilly USA, LLC | $602.49 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Exact Sciences Corporation | $381.51 | 2023-2025 | Cologuard Collection Kit |
| Esperion Therapeutics, INC. | $362.57 | 2020-2024 | Nexletol |
| Abbott Laboratories | $360.87 | 2021-2024 | Freestyle Libre 3, Proclaim, Eterna |
| Amgen INC. | $346.27 | 2019-2024 | Repatha, Otezla, Evenity |
| Corium, LLC | $316.68 | 2025 | Azstarys |
| Biohaven Pharmaceutical Holding Company LTD. | $168.44 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $163.73 | 2022-2025 | |
| Astellas Pharma US INC | $154.42 | 2023-2024 | Veozah, Myrbetriq |
| Takeda Pharmaceuticals U.S.A., INC. | $138.77 | 2019-2022 |
Show all 64 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Teri Stapleton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.